DE69834790D1 - Hysteresehyperthermie zur Behandlung eines Gewebes - Google Patents

Hysteresehyperthermie zur Behandlung eines Gewebes

Info

Publication number
DE69834790D1
DE69834790D1 DE69834790T DE69834790T DE69834790D1 DE 69834790 D1 DE69834790 D1 DE 69834790D1 DE 69834790 T DE69834790 T DE 69834790T DE 69834790 T DE69834790 T DE 69834790T DE 69834790 D1 DE69834790 D1 DE 69834790D1
Authority
DE
Germany
Prior art keywords
treatment
diseased tissue
tissue
magnetic material
magnetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69834790T
Other languages
English (en)
Other versions
DE69834790T2 (de
Inventor
Bruce Nathaniel Gray
Stephen Keith Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sirtex Medical Pty Ltd
Original Assignee
Sirtex Medical Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sirtex Medical Pty Ltd filed Critical Sirtex Medical Pty Ltd
Application granted granted Critical
Publication of DE69834790D1 publication Critical patent/DE69834790D1/de
Publication of DE69834790T2 publication Critical patent/DE69834790T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/12—Magnetotherapy using variable magnetic fields obtained by mechanical movement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
    • A61N1/406—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia using implantable thermoseeds or injected particles for localized hyperthermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
DE69834790T 1997-10-29 1998-10-27 Hysteresehyperthermie zur Behandlung eines Gewebes Expired - Lifetime DE69834790T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP0081A AUPP008197A0 (en) 1997-10-29 1997-10-29 Improved targeted hysteresis hyperthermia as a method for treating diseased tissue
AUPP008197 1997-10-29

Publications (2)

Publication Number Publication Date
DE69834790D1 true DE69834790D1 (de) 2006-07-20
DE69834790T2 DE69834790T2 (de) 2007-05-24

Family

ID=3804358

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69834790T Expired - Lifetime DE69834790T2 (de) 1997-10-29 1998-10-27 Hysteresehyperthermie zur Behandlung eines Gewebes

Country Status (11)

Country Link
US (1) US6149576A (de)
EP (1) EP0913167B1 (de)
JP (1) JP3677399B2 (de)
KR (1) KR19990037497A (de)
CN (1) CN1217219A (de)
AT (1) ATE328641T1 (de)
AU (1) AUPP008197A0 (de)
CA (1) CA2252199A1 (de)
DE (1) DE69834790T2 (de)
ES (1) ES2264188T3 (de)
TW (1) TW426532B (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN978296A0 (en) 1996-05-10 1996-05-30 Gray, Bruce N Targeted hysteresis hyperthermia as a method for treating cancer
AUPP899899A0 (en) * 1999-03-03 1999-03-25 Paragon Medical Limited Magnetic material
US6470220B1 (en) * 1999-03-29 2002-10-22 The Regents Of The University Of California Diagnosis and treatment of cancers using in vivo magnetic domains
DE19937493C2 (de) * 1999-08-07 2001-06-07 Mfh Hyperthermiesysteme Gmbh Magnetfeldapplikator zur Aufheizung von magnetischen oder magnetisierbaren Substanzen oder Festkörpern in biologischem Gewebe
DE19937492C2 (de) 1999-08-07 2001-08-23 Mfh Hyperthermiesysteme Gmbh Magnetfeldapplikator zur Aufheizung von magnetischen oder magnetisierbaren Substanzen oder Festkörpern in biologischem Gewebe
AUPR113100A0 (en) * 2000-10-30 2000-11-23 Australian National University, The Radio-labelled ferrite particles and methods for the manufacture and use thereof
DE10109105C2 (de) * 2001-02-24 2003-01-09 Mfh Hyperthermiesysteme Gmbh Magnetspulenanordnung eines Magnetfeldapplikators zur Aufheizung von magnetischen oder magnetisierbaren Substanzen oder Festkörpern in biologischem Gewebe
EP1251707A3 (de) * 2001-04-20 2003-09-24 Matsushita Electric Industrial Co., Ltd. Verfahren zum Suchen eines freien Funkkanals
US7731648B2 (en) 2001-07-25 2010-06-08 Aduro Biotech Magnetic nanoscale particle compositions, and therapeutic methods related thereto
US6997863B2 (en) 2001-07-25 2006-02-14 Triton Biosystems, Inc. Thermotherapy via targeted delivery of nanoscale magnetic particles
US7951061B2 (en) 2001-07-25 2011-05-31 Allan Foreman Devices for targeted delivery of thermotherapy, and methods related thereto
US7074175B2 (en) 2001-07-25 2006-07-11 Erik Schroeder Handy Thermotherapy via targeted delivery of nanoscale magnetic particles
US7918883B2 (en) * 2002-02-25 2011-04-05 Boston Scientific Scimed, Inc. Non-invasive heating of implanted vascular treatment device
US7249604B1 (en) * 2002-05-10 2007-07-31 Vasmo, Inc. Medical devices for occlusion of blood flow
US7670623B2 (en) 2002-05-31 2010-03-02 Materials Modification, Inc. Hemostatic composition
DE10238853A1 (de) * 2002-08-24 2004-03-04 Philips Intellectual Property & Standards Gmbh Verfahren zur lokalen Erwärmung mit magnetischen Partikeln
US7560160B2 (en) 2002-11-25 2009-07-14 Materials Modification, Inc. Multifunctional particulate material, fluid, and composition
AU2003900335A0 (en) * 2003-01-22 2003-02-13 Sirtex Medical Limited Microparticles for selectively targeted hyperthermia
DE602004008590T2 (de) * 2003-01-31 2008-05-21 Otsuka Pharmaceutical Factory, Inc., Naruto Hilfsstoff zum einsatz bei der krebstherapie mittels dielektrischer erwärmung und krebstherapieverfahren
US20040156846A1 (en) * 2003-02-06 2004-08-12 Triton Biosystems, Inc. Therapy via targeted delivery of nanoscale particles using L6 antibodies
US7007972B1 (en) 2003-03-10 2006-03-07 Materials Modification, Inc. Method and airbag inflation apparatus employing magnetic fluid
EP1615553B1 (de) * 2003-04-15 2017-01-18 Philips Intellectual Property & Standards GmbH Anordnung zur beeinflussung von magnetischen partikeln
WO2004091392A1 (en) 2003-04-15 2004-10-28 Philips Intellectual Property & Standards Gmbh Method and arrangement for influencing magnetic particles and detecting interfering material
US6982501B1 (en) 2003-05-19 2006-01-03 Materials Modification, Inc. Magnetic fluid power generator device and method for generating power
GB0313259D0 (en) * 2003-06-09 2003-07-16 Consejo Superior Investigacion Magnetic nanoparticles
US7200956B1 (en) 2003-07-23 2007-04-10 Materials Modification, Inc. Magnetic fluid cushioning device for a footwear or shoe
US20050090732A1 (en) * 2003-10-28 2005-04-28 Triton Biosystems, Inc. Therapy via targeted delivery of nanoscale particles
JP4492370B2 (ja) * 2005-01-31 2010-06-30 Ｔｄｋ株式会社 磁性発熱体及びそれに用いるフェライト
US20090081122A1 (en) * 2005-05-23 2009-03-26 Universite De Geneve Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
TWI314465B (en) * 2005-12-30 2009-09-11 Ind Tech Res Inst Thermosensitive nanostructure for hyperthermia treatment
ATE551703T1 (de) 2006-05-08 2012-04-15 Iner Aec Executive Yuan Lipiodol-magnetkomponente und zugehöriges herstellungsverfahren
WO2008060393A2 (en) * 2006-10-24 2008-05-22 Iso Therapeutics Group Llc The use of materials and external stimuli for synovectomy
JP4908299B2 (ja) * 2007-04-19 2012-04-04 株式会社東芝 超電導マグネット装置
WO2009091597A2 (en) 2008-01-16 2009-07-23 Nanospectra Biosciences, Inc. Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy
KR100889006B1 (ko) * 2008-10-30 2009-03-19 메가테크(주) 저주파 회전 영구자성체의 자장 치료장치
ES2672987T3 (es) 2009-03-02 2018-06-19 Yeda Research And Development Co. Ltd. Esquema de configuración magnética y sincronización para la estimulación magnética transcraneal
JP5750098B2 (ja) * 2009-05-08 2015-07-15 コーニンクレッカ フィリップス エヌ ヴェ 磁性材料の加熱のための装置及び方法
US8565892B2 (en) 2009-10-31 2013-10-22 Qteris, Inc. Nanoparticle-sized magnetic absorption enhancers having three-dimensional geometries adapted for improved diagnostics and hyperthermic treatment
US8968171B2 (en) 2011-01-24 2015-03-03 Endomagnetics Limited System for correlating energy field characteristics with target particle characteristics in the application of an energy field to a living organism for imaging and treatment of invasive agents
US20120190979A1 (en) 2011-01-24 2012-07-26 Actium BioSystems, LLC System for automatically amending energy field characteristics in the application of an energy field to a living organism for treatment of invasive agents
US20120190911A1 (en) * 2011-01-24 2012-07-26 Actium BioSystems, LLC Low temperature hyperthermia system for therapeutic treatment of invasive agents
US8757166B2 (en) 2011-01-24 2014-06-24 Actium BioSystems, LLC System for defining energy field characteristics to illuminate nano-particles used to treat invasive agents
US20120259154A1 (en) * 2011-04-05 2012-10-11 IVDiagnostics, Inc. In Vivo Immunomagnetic Hyperthermia Platform for Any Cell or Virus Having a Target Surface Receptor
WO2013032792A1 (en) 2011-08-26 2013-03-07 Actium BioSystems, LLC Apparatus for the generation of an energy field for the treatment of cancer in body cavities and parts that are cavity-like
TWI495450B (zh) * 2013-05-24 2015-08-11 Univ Central Taiwan Sci & Tech 植入式局部細胞組織加熱裝置
WO2015168062A1 (en) * 2014-04-28 2015-11-05 The Trustees Of Dartimouth College Method and magnetic catheter for magnetic nanoparticle treatment of the prostate
CN105920737A (zh) * 2016-06-07 2016-09-07 官爱平 用于肿瘤治疗的磁能系统和磁能加热方法
JP7200586B2 (ja) * 2018-10-09 2023-01-10 スミダコーポレーション株式会社 生体刺激用磁場発生装置
CN110207422A (zh) * 2019-06-18 2019-09-06 胡家华 一种生物电磁场驱动的磁制冷系统
KR102428203B1 (ko) * 2020-02-25 2022-08-04 서울대학교산학협력단 질병 치료를 위한 교류 자기장 발생 장치 및 시스템
CN111773545A (zh) * 2020-07-14 2020-10-16 同济大学 一种磁力磁热一体化装置

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303636A (en) * 1974-08-20 1981-12-01 Gordon Robert T Cancer treatment
US4106488A (en) * 1974-08-20 1978-08-15 Robert Thomas Gordon Cancer treatment method
US4323056A (en) * 1980-05-19 1982-04-06 Corning Glass Works Radio frequency induced hyperthermia for tumor therapy
US4392040A (en) * 1981-01-09 1983-07-05 Rand Robert W Induction heating apparatus for use in causing necrosis of neoplasm
US4574782A (en) * 1981-11-16 1986-03-11 Corning Glass Works Radio frequency-induced hyperthermia for tumor therapy
US4545368A (en) * 1983-04-13 1985-10-08 Rand Robert W Induction heating method for use in causing necrosis of neoplasm
US4662359A (en) * 1983-08-12 1987-05-05 Robert T. Gordon Use of magnetic susceptibility probes in the treatment of cancer
US4983159A (en) * 1985-03-25 1991-01-08 Rand Robert W Inductive heating process for use in causing necrosis of neoplasms at selective frequencies
JPH0288059A (ja) * 1988-09-26 1990-03-28 Univ Kyoto 温熱療法用セラミックス発熱体及びその製造方法
US5123989A (en) * 1989-06-14 1992-06-23 Toda Kogyo Corporation Resin-bonding method
US5197940A (en) * 1990-01-29 1993-03-30 Hypertherm Corp. Local application tumor treatment apparatus
US5411730A (en) * 1993-07-20 1995-05-02 Research Corporation Technologies, Inc. Magnetic microparticles

Also Published As

Publication number Publication date
US6149576A (en) 2000-11-21
EP0913167B1 (de) 2006-06-07
CN1217219A (zh) 1999-05-26
ATE328641T1 (de) 2006-06-15
JPH11197257A (ja) 1999-07-27
ES2264188T3 (es) 2006-12-16
TW426532B (en) 2001-03-21
EP0913167A2 (de) 1999-05-06
AUPP008197A0 (en) 1997-11-20
EP0913167A3 (de) 2000-03-08
DE69834790T2 (de) 2007-05-24
JP3677399B2 (ja) 2005-07-27
CA2252199A1 (en) 1999-04-29
KR19990037497A (ko) 1999-05-25

Similar Documents

Publication Publication Date Title
DE69834790D1 (de) Hysteresehyperthermie zur Behandlung eines Gewebes
DE69735481D1 (de) Verwendung eines magnetischen materials zur Herstellung eines Medikaments für gezielte Hysterese Hyperthermie
JPS57136463A (en) Method and apparatus used in killing tumor
DE69913665D1 (de) Verwendung von follistatin zur herstellung eines arzneimittels zur behandlung von muskuläre krankheiten
DE69636674D1 (de) Vorrichtung zur wärmebehandlung von gewebe
ATE244018T1 (de) Herstellungb und verwendung eines spezifischen gaba-aalpha5 rezeptorligands zur behandlung der erkrankung von alzheimer
DE69521406D1 (de) Apparat und verfahren zur herstellung fester formen mit gesteuerter freisetzung des wirkstoffs
CA2296057A1 (en) Therapeutic prostatic thermotherapy
ATE103189T1 (de) Chirurgisches material und verwendung des materials zur herstellung (eines teiles) einer anordnung zur verwendung in der knochenchirurgie.
CA2308335A1 (en) Device for magnetic field therapy
ATE249228T1 (de) Verwendung von polyallylamin-polymeren zur herstellung eines medikamentes zur behandlung von hypercholesterolemia
DE69124293T2 (de) Vorrichtung zur Behandlung von Wirbelsäulenerkrankungen
ATE237339T1 (de) Verwendung des modifizierten eigenen blutes zur behandlung von autoimmunerkrankungen
DE69202019D1 (de) Verwendung von essentiellen Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von AIDS.
DE69630321D1 (de) Vorrichtung zur örtlichen wärmebehandlung von gewebe
DE69635305D1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
ATE192495T1 (de) Carboxypeptidase-ähnliches protein aus knochen und verfahren zur dessen herstellung
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
NO20001799L (no) FremgangsmÕte for rensing av kirurgiske instrumenter
GR3034155T3 (en) Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer
AU6987696A (en) The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells
DE69026511D1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
FR2810876B1 (fr) Ensemble medical pour fixer a travers un conduit anatomique une doublure et un implant
EP0585801A3 (en) Bone-related cadherin-like protein and process for its production
SE8103305L (sv) Operationsdrekt

Legal Events

Date Code Title Description
8364 No opposition during term of opposition